SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011912
Filing Date
2018-08-14
Accepted
2018-08-14 17:29:45
Documents
46
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 438262
2 ex31-1.htm EX-31.1 12789
3 ex32-1.htm EX-32.1 4850
  Complete submission text file 0001493152-18-011912.txt   2375736

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE pcsa-20180630.xml EX-101.INS 301557
5 XBRL SCHEMA FILE pcsa-20180630.xsd EX-101.SCH 29904
6 XBRL CALCULATION FILE pcsa-20180630_cal.xml EX-101.CAL 40774
7 XBRL DEFINITION FILE pcsa-20180630_def.xml EX-101.DEF 103023
8 XBRL LABEL FILE pcsa-20180630_lab.xml EX-101.LAB 218304
9 XBRL PRESENTATION FILE pcsa-20180630_pre.xml EX-101.PRE 173073
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184948 | Film No.: 181019031
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1